Primer on Tumor Immunology and Biological Therapy
November 1, 2007
Seaport World Trade Center
Boston, Massachusetts
Primer Schedule (subject to change)
| 3:00 pm - 3:05 pm |
Welcome and Introduction |
| 3:05 pm - 3:40 pm |
Cancer Vaccines
Carmen Scheibenbogen, MD - Institut für Med. Immunologie, Charité, Berlin |
| 3:40 pm - 4:15 pm |
T Cell Therapy
Patrick Hwu, MD - MD Anderson Cancer Center |
| 4:15 pm - 4:50 pm |
Host-Tumor Interations
Francesco Marincola, MD - National Institutes of Health |
| 4:50 pm - 5:25 pm |
Vaccine Adjuvants, Antigen Processing and Immune Tolerance
Kenneth Rock, MD - University of Massachusetts |
| 5:25 pm - 5:45 pm |
Dinner Break |
| 5:45 pm - 6:20 pm |
In Vivo Immunity: Integrating Innate and Adaptive Immunity - The Role of Danger
Polly Matzinger, PhD - National Institutes of Allergy and Infectious Diseases |
| 6:20 pm - 6:55 pm |
Normalization of the Tumor Microenvironment by Antiangiogenic Therapy
Rakesh K. Jain, PhD - Harvard Medical School
|
| 6:55 pm - 7:30 pm |
Angiogenesis as an "Organizing Principle" in Biology
Judah Folkman, MD - Children's Hospital Boston |
| 7:30 pm - 8:05 pm |
Antibody Therapy, Biology, Immunocytokines and Hematologic Malignancy
Paul M. Sondel, MD, PhD - University of Wisconsin
|
| 8:05 pm - 8:15 pm |
Break |
| 8:15 pm - 8:50 pm |
Antibody Therapy of Solid Tumors
Louis M. Weiner, MD - Fox Chase Cancer Center |
| 8:50 pm - 9:25 pm |
Immunotoxin Therapy of Cancer: Successes and Challenges
Ira H. Pastan, MD - National Institutes of Health |
| 9:25 pm - 10:00 pm |
Cytokines in Malignancy
Kim A. Margolin, MD - City of Hope Cancer Center |
|
|
|
